Adam Feuerstein ✡️· @adamfeuerstein · X·· 7 小时前AI 评分32
AI 导读
$ERAS 明日将在 Triple Mtg 上公布其 pan-RASser($RVMD 的潜在竞争对手)的更新数据。悬念?其实没有。CEO Jon Lim 数周来一直向投资者表示,PDAC 中 ORR 达到“4 字头”、肺癌中达到“6 字头”就会让他满意。 本周 Biotech Scorecard: https://www.statnews.com/2026/11/19/erasca-kras-targeted-treatment-new-data-pancreatic-cancer/
正文
$ERAS presents an update on its pan-RASser (and potential $RVMD rival) tomorrow at the Triple Mtg. Suspense? Not really. CEO Jon Lim has been telling investors for weeks that a "4-handle" ORR in PDAC and a "6-handle" in lung will make him happy.
In this week's Biotech Scorecard:
https://www.statnews.com/2026/11/19/erasca-kras-targeted-treatment-new-data-pancreatic-cancer/
来源:Adam Feuerstein ✡️ · x.com